Diana Buist, PhD, MPH, is an epidemiologist and health services researcher with extensive experience conducting comparative effectiveness research. Her work focuses on reducing harms and increasing benefits for patients in the area of cancer screening and outcomes spanning across patient, provider, and system factors.
Dr. Buist has an extensive record of practical research that has led to many efforts to improve care, including the development and refinement of national breast cancer screening guidelines and their implementation within Kaiser Permanente Washington. She has been conducting research within Kaiser Permanente Washington for more than 20 years and is a strong believer in patient-centered care and the important role patients play in improving the value and quality of health care. Dr. Buist is involved in several studies aimed at providing high-value health care that provides patients and their providers with information on the expected benefits and harms of cancer screening and treatment strategies.
Dr. Buist also has a long history collaborating with external researchers, including helping lead two large national research consortia focused on improving cancer screening and outcomes: the National Cancer Institute’s Breast Cancer Surveillance Consortium and the Cancer Research Network of the Health Care Systems Research Network. Her extensive experience working with diverse data from these consortia in longitudinal studies and randomized trials in clinical systems puts Dr. Buist in a unique position to examine screening, care, and outcomes in health systems across the country.
As Kaiser Permanente Washington Health Research Institute (KPWHRI) Director of Research and Strategic Partnerships, Dr. Buist works with other Kaiser Permanente regions, our local academic partners, and other external collaborators to build enduring strategic partnerships to enhance KPWHRI’s mission, align with KPWHRI faculty research priorities, and capitalize on our unique strengths in ways that are consistent with our mission.
Dr. Buist contributes to a variety of other projects at KPWHRI, including:
Dr. Buist is also an affiliate professor in the Departments of Epidemiology and Health Services at the University of Washington School of Public Health and an affiliate member at Fred Hutchinson Cancer Research Center. She enjoys sharing her expertise by mentoring junior faculty and PhD and MPH candidates and teaching courses.
Cancer screening and prevention; outreach and primary care prevention; comparative effectiveness; cost transparency; surveillance; secondary prevention; breast cancer treatment; breast cancer screening; outcomes following cancer diagnosis; cancer survivorship; provider variability in care
Cancer prevention and control; quality of care; preventive care; high-value care; consumer engagement in preventive medicine; systematic reviews
Cancer prevention and control
LaCroix AZ, Newton KM, Buist DSM, Curry SJ, Scholes D, Anderson LA, Keenan NL. Population-based strategy for improving informed decision-making about hormone replacement therapy in managed care settings. Women's Health Issues. 1999;9:306-318.
Newton KM, LaCroix AZ, Buist DSM, Keenan NL. The use of alternative and complementary medicine by women enrolled in an HMO setting. Menopause. 1998;4:263.
Buist DSM, LaCroix AZ, Newton KM. Long-term Hormone Replacement Therapy (HRT) users: are they different and why do they persist? Am J Epidemiol. 1997;145:S1.
Newton KM, LaCroix AZ, Buist DSM. Do providers encourage HRT use for women at high risk of coronary disease? A focus on attitudes and prescribing behaviors. Circulation. 1997;96(suppl) :131.
LaCroix AZ, Newton KM, Buist DSM, Keenan NL, Anderson LA. What factors account for differences in HRT prescribing by healthcare providers in a health maintenance organization? The EnPower Provider Survey. Menopause. 1997;4:262.
Anderson LA, Caplan LS, Buist DSM, Newton KM, Curry S, LaCroix AZ. Counseling about HRT: perceived barriers and recommendations among primary care providers. Menopause. 1997;4:263.
Newton KM, Anderson LA, LaCroix AZ, Buist DSM, Keenan NL. Healthcare provider characteristics and encouragement to use HRT: the EnPower provider survey. Menopause. 1997;4:263.
A Kaiser Permanente-led BCSC study is among the largest ever to evaluate adding MRI surveillance for breast cancer survivors.
Kaiser Permanente Share profiles longtime KPWHRI investigator and director of research and strategic partnerships.
Read it in News and Events.
Kaiser Permanente Washington has been part of the national Breast Cancer Surveillance Consortium since 1994. Learn about the Kaiser Permanente Washington Breast Cancer Surveillance Registry here.
Every year the KPWHRI award recognizes two individuals who provide outstanding service in promoting the career development of others.
KP Washington joins forces with UW, WSU, and the VA to train scientists in transforming health care.
Could at-home kits help save more lives? Drs. Diana Buist and Rachel Winer are on a journey to find out.